# Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis

> **NCT00696969** · PHASE3 · COMPLETED · sponsor: **Drugs for Neglected Diseases** · enrollment: 634 (actual)

## Conditions studied

- Visceral Leishmaniasis

## Interventions

- **DRUG:** Amphotericin B Deoxycholate
- **DRUG:** Ambisome + Miltefosine
- **DRUG:** Ambisome and Paromomycin
- **DRUG:** Miltefosine and Paromomycin

## Key facts

- **NCT ID:** NCT00696969
- **Lead sponsor:** Drugs for Neglected Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 634 (ACTUAL)
- **Last updated:** 2010-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696969, "Safety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral Leishmaniasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00696969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*